Synthego Unveils GMP SpCas9 for Advanced Gene Editing Capabilities Synthego announces the launch of GMP SpCas9, a groundbreaking advancement in CRISPR technology, designed to facilitate gene editing for therapeutic purposes.

Synthego Unveils GMP SpCas9 for Advanced Gene Editing Capabilities #USA #Redwood_City #CRISPR_Technology #Synthego #GMP_SpCas9